Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-08-04 | Translational 1 | ETA2023

Association between BMI and Brafv600E mutation status may differ by primary tumor size

Park Hyunju , Heo Jung , Jin Ryu Hyun , Hyuk Kim Tae , Wook Kim Sun , Hoon Chung Jae

Introduction: The prevalence of B-type Raf kinase (BRAFV600E) mutation in PTC has been observed in 30% to over 80%, and it seems that the mutation occurred in the early stage of thyroid carcinoma progression which precedes histological change. Based on previous reports, high body mass index (BMI) is considered a thyroid cancer risk. However, it is unclear whether high BMI has a certain association with the BRAFV600E mutational status. We assess whether high BMI is associated w...

ea0092ps1-08-05 | Translational 1 | ETA2023

Can tert promoter mutation be a poor prognostic factor in undifferentiated thyroid carcinoma?

Ryu HyunJin , Lyun Oh Young , Heo Jung , Park Hyunju , Hyuk Kim Tae , Wook Kim Sun , Hoon Chung Jae

Background: Telomerase reverse transcriptase (TERT) promoter mutation is a poor prognostic factor in differentiated thyroid carcinoma(DTC). It is thought to play a role in the transformation process to undifferentiated thyroid carcinoma(UTC), but its role as a prognostic factor in UTC is unclear. Therefore, in this study, we investigated whether the TERT promoter mutation acts as as an independent poor prognostic factor in UTC.Methods: Among patients dia...

ea0049gp219 | Thyroid 3 | ECE2017

Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy in patients with differentiated thyroid cancer

In Kim Hye , Hyuk Kim Tae , Nam Kim Young , Kim Hosu , Young Park So , Jae Chung Yun , Hoon Chung Jae , Wook Kim Sun

Background: Delayed thyroid-stimulating hormone (TSH) recovery during treatment of GravesÂ’ disease is caused by long-term excessive thyroid hormone, which results in down-regulation of pituitary thyrotropic cells. However, it is unknown whether delayed TSH recovery exists after levothyroxine (LT4) dose adjustment in patients with differentiated thyroid cancer (DTC) who are taking a suppressive dose of LT4.Methods: We retrospectively reviewed 97 DTC ...

ea0041ep984 | Thyroid (non-cancer) | ECE2016

Incidence and prevalence of overt hypothyroidism and causative diseases in Korea as determined using claims data provided by the health insurance review and assessment service

Wook Kim Sun , Hoon Chung Jae , Jeong Kim Hye , Young Sohn Seo , Nam Kim Young , Lee You-Bin , Kim Hye-In , Lee Seung-Eun

Background: The incidence and prevalence of overt hypothyroidism have been reported to be 2 to 4/1,000 population/year and 8 to 13/1,000 population, respectively, in foreign countries. As there has been no nationwide survey to obtain data in Korea, the present study investigated the incidence and prevalence of overt hypothyroidism in Korea using claims data provided by the Health Insurance Review and Assessment Service. The proportions of causative diseases for hypothyroidism ...

ea0041ep986 | Thyroid (non-cancer) | ECE2016

Selenium concentration in Korean patients with thyroid disease: a preliminary report

Wook Kim Sun , Hoon Chung Jae , Jeong Kim Hye , Young Sohn Seo , Nam Kim Young , Lee You-Bin , Kim Hye-In , Lee Seung-Eun

Background: Selenium is an important trace element for thyroid hormone metabolism and its deficiency can cause hypothyroidism. Serum or plasma selenium concentration has been known as best biomarker which reflects selenium intake and reserve. We preliminarily assessed the serum or urine selenium concentrations in patients with thyroid disease compared to healthy normal population. We also investigated the correlation of serum selenium concentration with urine selenium concentr...

ea0092ps3-26-04 | Thyroid hormone diagnostics 2 | ETA2023

Diagnostic performance of 18F-choline PET/CT for detection of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism: a single-center experience

Heo Jung , Park Hyunju , Hyuk Kim Tae , Hoon Chung Jae , Wook Kim Sun , Yang Heera , Soo Kim Jee , Ho Choe Jun , Han Kim Jung , Seok Cho Young , Young Choi Joon

Objectives: 18F-choline PET/CT is a recently introduced imaging modality to localize hyperfunctioning parathyroid glands in patient with hyperparathyroidism. But there has been no study according the diagnostic power of 18F-choline PET/CT in Korea so far owing to its limited distribution. Therefore, we evaluated the diagnostic performance of 18F-choline PET/CT in detection of hyperfunctioning parathyroid gland in patients with primary hyperpara...